Biotechnology - , California, United States
Chief Technology Officer
Contact Woytek Bartkowski
Investor
Contact Ben Pouladian
Didadem Biotherapeutics is pioneering the development of first-in-class engineered exosomes to treat chronic inflammatory and auto-immune conditions.
Gmail
NSOne
Typekit
Mobile Friendly